Birdwatch Note
2024-12-20 05:32:18 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
While it's true that Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended granting market authorisation to Kostaive, a COVID-19 self-amplifying mRNA vaccine, there's no indication any of its components can "spread to unvaccinated people." https://www.japantimes.co.jp/news/2024/10/07/japan/science-health/replicon-vaccine-fears/ https://www.ema.europa.eu/en/medicines/human/EPAR/kostaive https://www.nature.com/articles/s41467-024-47905-1 https://www.mdpi.com/2076-0817/12/1/138
Written by B7CB048B9064EAC42AE55A14A42938CAA3891D64695207A18E21D9AFD615858D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1869832597003710713
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1869979115266420829
- noteId - 1869979115266420829
- participantId -
- noteAuthorParticipantId - B7CB048B9064EAC42AE55A14A42938CAA3891D64695207A18E21D9AFD615858D Participant Details
- createdAtMillis - 1734672738268
- tweetId - 1869832597003710713
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- While it's true that Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended granting market authorisation to Kostaive, a COVID-19 self-amplifying mRNA vaccine, there's no indication any of its components can "spread to unvaccinated people." https://www.japantimes.co.jp/news/2024/10/07/japan/science-health/replicon-vaccine-fears/ https://www.ema.europa.eu/en/medicines/human/EPAR/kostaive https://www.nature.com/articles/s41467-024-47905-1 https://www.mdpi.com/2076-0817/12/1/138
Note Ratings
| rated at | rated by | |
| 2024-12-20 18:42:04 -0600 | Rating Details | |
| 2024-12-20 18:09:09 -0600 | Rating Details | |
| 2024-12-20 17:18:40 -0600 | Rating Details | |
| 2024-12-20 17:16:33 -0600 | Rating Details | |
| 2024-12-20 17:11:38 -0600 | Rating Details | |
| 2024-12-20 16:49:51 -0600 | Rating Details | |
| 2024-12-20 15:52:23 -0600 | Rating Details | |
| 2024-12-20 15:38:08 -0600 | Rating Details | |
| 2024-12-20 15:37:12 -0600 | Rating Details | |
| 2024-12-20 15:10:03 -0600 | Rating Details | |
| 2024-12-20 14:10:52 -0600 | Rating Details | |
| 2024-12-20 13:49:17 -0600 | Rating Details | |
| 2024-12-20 13:48:58 -0600 | Rating Details | |
| 2024-12-20 13:40:14 -0600 | Rating Details | |
| 2024-12-20 13:39:59 -0600 | Rating Details | |
| 2024-12-20 13:34:03 -0600 | Rating Details | |
| 2024-12-20 13:30:11 -0600 | Rating Details | |
| 2024-12-20 13:23:42 -0600 | Rating Details | |
| 2024-12-20 13:22:04 -0600 | Rating Details | |
| 2024-12-20 13:21:39 -0600 | Rating Details | |
| 2024-12-20 13:10:21 -0600 | Rating Details | |
| 2024-12-20 13:10:10 -0600 | Rating Details | |
| 2024-12-20 13:00:23 -0600 | Rating Details | |
| 2024-12-20 11:59:09 -0600 | Rating Details | |
| 2024-12-20 11:32:59 -0600 | Rating Details | |
| 2024-12-20 11:25:41 -0600 | Rating Details | |
| 2024-12-20 11:21:38 -0600 | Rating Details | |
| 2024-12-20 11:11:59 -0600 | Rating Details | |
| 2024-12-20 11:06:06 -0600 | Rating Details | |
| 2024-12-20 11:04:17 -0600 | Rating Details | |
| 2024-12-20 10:53:13 -0600 | Rating Details | |
| 2024-12-20 10:44:24 -0600 | Rating Details | |
| 2024-12-20 10:40:30 -0600 | Rating Details | |
| 2024-12-20 10:21:38 -0600 | Rating Details | |
| 2024-12-20 10:09:01 -0600 | Rating Details | |
| 2024-12-20 09:31:59 -0600 | Rating Details | |
| 2024-12-20 09:28:51 -0600 | Rating Details | |
| 2024-12-20 09:23:29 -0600 | Rating Details | |
| 2024-12-20 09:05:26 -0600 | Rating Details | |
| 2024-12-20 09:05:03 -0600 | Rating Details | |
| 2024-12-20 08:51:28 -0600 | Rating Details | |
| 2024-12-20 08:30:07 -0600 | Rating Details | |
| 2024-12-20 08:24:05 -0600 | Rating Details | |
| 2024-12-20 08:23:45 -0600 | Rating Details | |
| 2024-12-20 08:23:06 -0600 | Rating Details | |
| 2024-12-20 07:59:07 -0600 | Rating Details | |
| 2024-12-20 07:54:09 -0600 | Rating Details | |
| 2024-12-20 07:34:26 -0600 | Rating Details | |
| 2024-12-20 07:30:13 -0600 | Rating Details | |
| 2024-12-20 07:08:36 -0600 | Rating Details | |
| 2024-12-20 06:59:46 -0600 | Rating Details | |
| 2024-12-20 06:52:21 -0600 | Rating Details | |
| 2024-12-20 06:49:23 -0600 | Rating Details | |
| 2024-12-20 06:44:54 -0600 | Rating Details | |
| 2024-12-20 06:36:17 -0600 | Rating Details | |
| 2024-12-20 06:13:12 -0600 | Rating Details | |
| 2024-12-20 06:11:12 -0600 | Rating Details | |
| 2024-12-20 05:58:52 -0600 | Rating Details | |
| 2024-12-20 05:51:14 -0600 | Rating Details | |
| 2024-12-20 05:46:12 -0600 | Rating Details | |
| 2024-12-20 05:37:50 -0600 | Rating Details | |
| 2024-12-20 05:30:46 -0600 | Rating Details | |
| 2024-12-20 05:28:43 -0600 | Rating Details | |
| 2024-12-20 05:21:42 -0600 | Rating Details | |
| 2024-12-20 05:18:13 -0600 | Rating Details | |
| 2024-12-20 05:10:39 -0600 | Rating Details | |
| 2024-12-20 05:04:27 -0600 | Rating Details | |
| 2024-12-20 05:03:26 -0600 | Rating Details | |
| 2024-12-20 04:43:37 -0600 | Rating Details | |
| 2024-12-20 04:40:51 -0600 | Rating Details | |
| 2024-12-20 04:03:30 -0600 | Rating Details | |
| 2024-12-20 03:55:10 -0600 | Rating Details | |
| 2024-12-20 03:47:58 -0600 | Rating Details | |
| 2024-12-20 03:45:13 -0600 | Rating Details | |
| 2024-12-20 03:28:58 -0600 | Rating Details | |
| 2024-12-20 03:15:43 -0600 | Rating Details | |
| 2024-12-20 02:50:30 -0600 | Rating Details | |
| 2024-12-20 02:49:18 -0600 | Rating Details | |
| 2024-12-20 02:29:07 -0600 | Rating Details | |
| 2024-12-20 01:30:17 -0600 | Rating Details | |
| 2024-12-20 01:13:17 -0600 | Rating Details | |
| 2024-12-20 01:12:37 -0600 | Rating Details | |
| 2024-12-20 01:08:50 -0600 | Rating Details | |
| 2024-12-20 00:58:14 -0600 | Rating Details | |
| 2024-12-20 00:14:21 -0600 | Rating Details | |
| 2024-12-19 23:56:06 -0600 | Rating Details | |
| 2024-12-19 23:44:20 -0600 | Rating Details | |
| 2024-12-19 23:42:04 -0600 | Rating Details |